AIM Concept Integration
4th Year MBBS
RENAL Module
4th Year MBBS
RENAL Module
Epidemiology and Foundations of Biostatistics
Connect epidemiological questions, study designs, disease measures, screening, data, sampling and bias into one rapid-revision framework.
1. THE TOPIC IN ONE CONNECTED FLOW
Epidemiology begins with a health problem in a defined population and asks how frequently it occurs, how it is distributed and what factors may influence it. Study design determines how evidence is collected, while biostatistics, sampling and control of bias determine how confidently that evidence can be interpreted.
START
Population Health Problem
Who, where, when and how much?
→
DESIGN
Choose Study Design
Describe, compare or intervene
→
MEASURE
Quantify Disease
Incidence, prevalence and mortality
→
DETECT
Apply Screening
Identify possible unrecognized disease
→
DATA
Classify & Sample
Variables + representative sample
→
VALIDITY
Control Bias
Reduce systematic distortion
→
INTERPRET
Biostatistical Inference
Turn observations into evidence
2. KEY CLINICAL CONNECTIONS
Screening → Diagnostic Pathway
Apparently healthy population
→
screening test
→
screen-positive individual
→
diagnostic evaluation
→
screening test
→
screen-positive individual
→
diagnostic evaluation
Sensitivity limits false negatives; specificity limits false positives. Predictive values also depend on disease prevalence.
Disease Occurrence → Disease Burden
New cases
→
incidence
→
cases remain with disease
→
prevalence
→
incidence
→
cases remain with disease
→
prevalence
Longer disease duration can keep prevalence high even when relatively few new cases occur.
Sampling → Valid Interpretation
Target population
→
representative sample
→
standardized measurement
→
more valid inference
→
representative sample
→
standardized measurement
→
more valid inference
Poor selection causes selection bias; inaccurate measurement causes information bias; confounding can distort an exposure–outcome relationship.
3. AIM HIGH-YIELD INTEGRATION REVIEW
⭐ Study direction guides design: disease-first reasoning supports case-control; exposure-first follow-up supports cohort.
A cross-sectional study gives a population snapshot, so it is useful for prevalence but may not establish whether exposure preceded outcome.
⭐ Incidence measures new disease, while prevalence reflects existing burden and is influenced by disease duration.
Screening identifies people needing further assessment; a positive result is presumptive, not a confirmed diagnosis.
⭐ High disease prevalence generally increases positive predictive value, even when sensitivity and specificity remain unchanged.
Mortality interpretation depends on the denominator: population denominators describe mortality rates, while diseased individuals form the denominator for case fatality.
Probability sampling strengthens representativeness, while standardized definitions and measurements reduce information bias.
⭐ Increasing sample size can improve precision, but it does not remove systematic bias caused by faulty selection or measurement.
AIM Exam Trap:
A ratio compares two quantities, a proportion has a numerator contained within its denominator, and a rate relates event occurrence to a population over time.
A ratio compares two quantities, a proportion has a numerator contained within its denominator, and a rate relates event occurrence to a population over time.